Sichenzia Ross Ference Kesner LLP Congratulates AYTU Biosciences, Inc., on NASDAQ Uplisting
Press Release – New York, NY – October 19, 2017 – Sichenzia Ross Ference Kesner LLP announced today that the Firm represented AYTU Biosciences, Inc. (NASDAQ: AYTU), in the Company’s up-listing to the NASDAQ Capital Market. The Sichenzia Ross Ference Kesner LLP team was led by founding Partner Gregory Sichenzia and Partner Marcelle Balcombe. The up-listing is effective for trading on October 20, 2017 and AYTU’s common stock will trade under its existing stock symbol “AYTU.”
“We congratulate AYTU on this milestone, one we believe will support the Company’s strategic capital markets objectives as it continues to market its therapies for low testosterone in men and diagnosing male infertility,” said Gregory Sichenzia, founding partner of Sichenzia Ross Ference Kesner LLP.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $52 Million Underwritten Public Offering - November 15, 2018
- Sichenzia Ross Ference LLP Ranked by U.S. News for its “Best Lawyers List” for 2019 - November 13, 2018
- Sichenzia Ross Ference Represents Pareteum Corporation in Definitive Agreement to Acquire iPass, Inc. - November 13, 2018